These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


731 related items for PubMed ID: 18633915

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
    Donnellan F, Harewood GC, Patchett SE.
    Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ, Spechler SJ.
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract] [Full Text] [Related]

  • 10. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
    O'Riordan JM, Byrne PJ, Ravi N, Keeling PW, Reynolds JV.
    Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE, Schmitz SM, Shaheen NJ.
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [Abstract] [Full Text] [Related]

  • 17. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR.
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Barrett's adenocarcinoma 52 years after subtotal esophagectomy for pediatric peptic stricture.
    Dunn LJ, Robertson AG, Immanuel A, Griffin SM.
    Ann Thorac Surg; 2010 Feb; 89(2):604-6. PubMed ID: 20103354
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.